Mills T A, Greenwood S L, Devlin G, Shweikh Y, Robinson M, Cowley E, Hayward C E, Cottrell E C, Tropea T, Brereton M F, Dalby-Brown W, Wareing M
School of Nursing, Midwifery and Social Work, The University of Manchester, Jean McFarlane Building, Oxford Road, Manchester M13 9PL, United Kingdom.
Maternal and Fetal Health Research Centre, Institute of Human Development, The University of Manchester, Manchester Academic Health Science Centre, St. Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, United Kingdom.
Placenta. 2015 Jun;36(6):638-44. doi: 10.1016/j.placenta.2015.03.007. Epub 2015 Mar 21.
Potassium (K(+)) channels are key regulators of vascular smooth muscle cell (VSMC) excitability. In systemic small arteries, Kv7 channel expression/activity has been noted and a role in vascular tone regulation demonstrated. We aimed to demonstrate functional Kv7 channels in human fetoplacental small arteries.
Human placental chorionic plate arteries (CPAs) were obtained at term. CPA responses to Kv7 channel modulators was determined by wire myography. Presence of Kv7 channel mRNA (encoded by KCNQ1-5) and protein expression were assessed by RT-PCR and immunohistochemistry/immunofluorescence, respectively.
Kv7 channel blockade with linopirdine increased CPA basal tone and AVP-induced contraction. Pre-contracted CPAs (AVP; 80 mM K(+) depolarization solution) exhibited significant relaxation to flupirtine, retigabine, the acrylamide (S)-1, and (S) BMS-204352, differential activators of Kv7.1 - Kv7.5 channels. All CPAs assessed expressed KCNQ1 and KCNQ3-5 mRNA; KCNQ2 was expressed only in a subset of CPAs. Kv7 protein expression was confirmed in intact CPAs and isolated VSMCs.
Kv7 channels are present and active in fetoplacental vessels, contributing to vascular tone regulation in normal pregnancy. Targeting these channels may represent a therapeutic intervention in pregnancies complicated by increased vascular resistance.
钾离子(K⁺)通道是血管平滑肌细胞(VSMC)兴奋性的关键调节因子。在全身小动脉中,已发现Kv7通道的表达/活性,并证实其在血管张力调节中起作用。我们旨在证明人胎盘小动脉中存在功能性Kv7通道。
足月时获取人胎盘绒毛板动脉(CPA)。通过线肌张力测定法确定CPA对Kv7通道调节剂的反应。分别通过逆转录聚合酶链反应(RT-PCR)和免疫组织化学/免疫荧光评估Kv7通道mRNA(由KCNQ1 - 5编码)的存在和蛋白质表达。
利诺吡啶阻断Kv7通道可增加CPA基础张力和血管加压素(AVP)诱导的收缩。预收缩的CPA(AVP;80 mM K⁺去极化溶液)对氟吡汀、瑞替加滨、丙烯酰胺(S)-1和(S)BMS - 204352(Kv7.1 - Kv7.5通道的不同激活剂)表现出显著舒张。所有评估的CPA均表达KCNQ1和KCNQ3 - 5 mRNA;KCNQ2仅在部分CPA中表达。在完整的CPA和分离的VSMC中证实了Kv7蛋白表达。
Kv7通道存在于胎儿 - 胎盘血管中并具有活性,有助于正常妊娠中的血管张力调节。针对这些通道可能是对伴有血管阻力增加的妊娠进行治疗干预的一种方法。